Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Herpes labialis, also known as cold sores, is a type of infection by the herpes simplex virus that affects primarily the lip. Symptoms typically include a burning pain followed by small blisters or sores. The first attack may also be accompanied by fever, sore throat, and enlarged lymph nodes. The rash usually heals within 10 days, but the virus remains dormant in the facial nerve. The virus may periodically reactivate to create another outbreak of sores in the mouth or lip.
With over 35% value share, North America stood the top market for herpes labialis treatment in 2019. This region is expected to continue its dominance through the forecast period, followed by Western Europe, which recorded over 20% share of the total market value in 2019.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Herpes Labialis Treatment market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Herpes Labialis Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Herpes Labialis Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline
Pfizer
Novartis
Teva
Sun
Dr Reddy's
Abbott
Mylan
By Type:
Acyclovir
Valacyclovir
Famciclovir
Penciclovir
Docosanol
By End-User:
Topical
Oral
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Herpes Labialis Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 USA Herpes Labialis Treatment Market Size and Growth Rate of Acyclovir from 2016 to 2027
-
1.3.2 USA Herpes Labialis Treatment Market Size and Growth Rate of Valacyclovir from 2016 to 2027
-
1.3.3 USA Herpes Labialis Treatment Market Size and Growth Rate of Famciclovir from 2016 to 2027
-
1.3.4 USA Herpes Labialis Treatment Market Size and Growth Rate of Penciclovir from 2016 to 2027
-
1.3.5 USA Herpes Labialis Treatment Market Size and Growth Rate of Docosanol from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Herpes Labialis Treatment Market Size and Growth Rate of Topical from 2016 to 2027
-
1.4.2 USA Herpes Labialis Treatment Market Size and Growth Rate of Oral from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Herpes Labialis Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Herpes Labialis Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Acyclovir
-
3.4.2 Market Size and Growth Rate of Valacyclovir
-
3.4.3 Market Size and Growth Rate of Famciclovir
-
3.4.4 Market Size and Growth Rate of Penciclovir
-
3.4.5 Market Size and Growth Rate of Docosanol
4 Segmentation of Herpes Labialis Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Herpes Labialis Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Herpes Labialis Treatment in Topical
-
4.4.2 Market Size and Growth Rate of Herpes Labialis Treatment in Oral
5 Market Analysis by Regions
-
5.1 USA Herpes Labialis Treatment Production Analysis by Regions
-
5.2 USA Herpes Labialis Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Herpes Labialis Treatment Landscape Analysis
-
6.1 West USA Herpes Labialis Treatment Landscape Analysis by Major Types
-
6.2 West USA Herpes Labialis Treatment Landscape Analysis by Major End-Users
7 South USA Herpes Labialis Treatment Landscape Analysis
-
7.1 South USA Herpes Labialis Treatment Landscape Analysis by Major Types
-
7.2 South USA Herpes Labialis Treatment Landscape Analysis by Major End-Users
8 Middle West USA Herpes Labialis Treatment Landscape Analysis
-
8.1 Middle West USA Herpes Labialis Treatment Landscape Analysis by Major Types
-
8.2 Middle West USA Herpes Labialis Treatment Landscape Analysis by Major End-Users
9 Northeast USA Herpes Labialis Treatment Landscape Analysis
-
9.1 Northeast USA Herpes Labialis Treatment Landscape Analysis by Major Types
-
9.2 Northeast USA Herpes Labialis Treatment Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 GlaxoSmithKline
-
10.1.1 GlaxoSmithKline Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Pfizer
-
10.2.1 Pfizer Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Novartis
-
10.3.1 Novartis Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Teva
-
10.4.1 Teva Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Sun
-
10.5.1 Sun Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Dr Reddy's
-
10.6.1 Dr Reddy's Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Abbott
-
10.7.1 Abbott Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Mylan
-
10.8.1 Mylan Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Herpes Labialis Treatment Market Size and Growth Rate of Acyclovir from 2016 to 2027
-
Figure USA Herpes Labialis Treatment Market Size and Growth Rate of Valacyclovir from 2016 to 2027
-
Figure USA Herpes Labialis Treatment Market Size and Growth Rate of Famciclovir from 2016 to 2027
-
Figure USA Herpes Labialis Treatment Market Size and Growth Rate of Penciclovir from 2016 to 2027
-
Figure USA Herpes Labialis Treatment Market Size and Growth Rate of Docosanol from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Herpes Labialis Treatment Market Size and Growth Rate of Topical from 2016 to 2027
-
Figure USA Herpes Labialis Treatment Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Herpes Labialis Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Herpes Labialis Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Herpes Labialis Treatment
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Herpes Labialis Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Herpes Labialis Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Acyclovir
-
Figure Market Size and Growth Rate of Valacyclovir
-
Figure Market Size and Growth Rate of Famciclovir
-
Figure Market Size and Growth Rate of Penciclovir
-
Figure Market Size and Growth Rate of Docosanol
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Herpes Labialis Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Herpes Labialis Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Topical
-
Figure Market Size and Growth Rate of Oral
-
Table USA Herpes Labialis Treatment Production by Regions
-
Table USA Herpes Labialis Treatment Production Share by Regions
-
Figure USA Herpes Labialis Treatment Production Share by Regions in 2016
-
Figure USA Herpes Labialis Treatment Production Share by Regions in 2021
-
Figure USA Herpes Labialis Treatment Production Share by Regions in 2027
-
Table USA Herpes Labialis Treatment Consumption by Regions
-
Table USA Herpes Labialis Treatment Consumption Share by Regions
-
Figure USA Herpes Labialis Treatment Consumption Share by Regions in 2016
-
Figure USA Herpes Labialis Treatment Consumption Share by Regions in 2021
-
Figure USA Herpes Labialis Treatment Consumption Share by Regions in 2027
-
Table West USA Herpes Labialis Treatment Consumption by Types from 2016 to 2027
-
Table West USA Herpes Labialis Treatment Consumption Share by Types from 2016 to 2027
-
Figure West USA Herpes Labialis Treatment Consumption Share by Types in 2016
-
Figure West USA Herpes Labialis Treatment Consumption Share by Types in 2021
-
Figure West USA Herpes Labialis Treatment Consumption Share by Types in 2027
-
Table West USA Herpes Labialis Treatment Consumption by End-Users from 2016 to 2027
-
Table West USA Herpes Labialis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Herpes Labialis Treatment Consumption Share by End-Users in 2016
-
Figure West USA Herpes Labialis Treatment Consumption Share by End-Users in 2021
-
Figure West USA Herpes Labialis Treatment Consumption Share by End-Users in 2027
-
Table South USA Herpes Labialis Treatment Consumption by Types from 2016 to 2027
-
Table South USA Herpes Labialis Treatment Consumption Share by Types from 2016 to 2027
-
Figure South USA Herpes Labialis Treatment Consumption Share by Types in 2016
-
Figure South USA Herpes Labialis Treatment Consumption Share by Types in 2021
-
Figure South USA Herpes Labialis Treatment Consumption Share by Types in 2027
-
Table South USA Herpes Labialis Treatment Consumption by End-Users from 2016 to 2027
-
Table South USA Herpes Labialis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Herpes Labialis Treatment Consumption Share by End-Users in 2016
-
Figure South USA Herpes Labialis Treatment Consumption Share by End-Users in 2021
-
Figure South USA Herpes Labialis Treatment Consumption Share by End-Users in 2027
-
Table Middle West USA Herpes Labialis Treatment Consumption by Types from 2016 to 2027
-
Table Middle West USA Herpes Labialis Treatment Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Herpes Labialis Treatment Consumption Share by Types in 2016
-
Figure Middle West USA Herpes Labialis Treatment Consumption Share by Types in 2021
-
Figure Middle West USA Herpes Labialis Treatment Consumption Share by Types in 2027
-
Table Middle West USA Herpes Labialis Treatment Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Herpes Labialis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Herpes Labialis Treatment Consumption Share by End-Users in 2016
-
Figure Middle West USA Herpes Labialis Treatment Consumption Share by End-Users in 2021
-
Figure Middle West USA Herpes Labialis Treatment Consumption Share by End-Users in 2027
-
Table Northeast USA Herpes Labialis Treatment Consumption by Types from 2016 to 2027
-
Table Northeast USA Herpes Labialis Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Herpes Labialis Treatment Consumption Share by Types in 2016
-
Figure Northeast USA Herpes Labialis Treatment Consumption Share by Types in 2021
-
Figure Northeast USA Herpes Labialis Treatment Consumption Share by Types in 2027
-
Table Northeast USA Herpes Labialis Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Herpes Labialis Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Herpes Labialis Treatment Consumption Share by End-Users in 2016
-
Figure Northeast USA Herpes Labialis Treatment Consumption Share by End-Users in 2021
-
Figure Northeast USA Herpes Labialis Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Sun
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun
-
Figure Sales and Growth Rate Analysis of Sun
-
Figure Revenue and Market Share Analysis of Sun
-
Table Product and Service Introduction of Sun
-
Table Company Profile and Development Status of Dr Reddy's
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's
-
Figure Sales and Growth Rate Analysis of Dr Reddy's
-
Figure Revenue and Market Share Analysis of Dr Reddy's
-
Table Product and Service Introduction of Dr Reddy's
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
